Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-03-03 @ 4:03 PM
Study NCT ID:
NCT01667133
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2012-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Ariad Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AP24534-11-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None